Trexquant Investment LP grew its holdings in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 56.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,922,012 shares of the company's stock after purchasing an additional 693,738 shares during the period. Trexquant Investment LP owned approximately 0.35% of UiPath worth $19,797,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Versant Capital Management Inc increased its holdings in shares of UiPath by 198.6% during the first quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after purchasing an additional 1,970 shares during the period. CX Institutional acquired a new position in shares of UiPath during the first quarter valued at $36,000. Brooklyn Investment Group increased its holdings in shares of UiPath by 314.3% during the first quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock valued at $46,000 after purchasing an additional 3,420 shares during the period. True Wealth Design LLC increased its holdings in shares of UiPath by 18.4% during the fourth quarter. True Wealth Design LLC now owns 5,163 shares of the company's stock valued at $66,000 after purchasing an additional 801 shares during the period. Finally, National Bank of Canada FI acquired a new position in shares of UiPath during the first quarter valued at $72,000. 62.50% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at UiPath
In related news, CFO Ashim Gupta sold 56,322 shares of UiPath stock in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $12.72, for a total value of $716,415.84. Following the transaction, the chief financial officer owned 859,991 shares of the company's stock, valued at approximately $10,939,085.52. This trade represents a 6.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction dated Wednesday, July 16th. The stock was sold at an average price of $12.43, for a total value of $559,350.00. Following the completion of the transaction, the chief executive officer directly owned 5,058,376 shares in the company, valued at $62,875,613.68. This represents a 0.88% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 831,310 shares of company stock worth $10,428,922 in the last three months. 23.19% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
PATH has been the topic of a number of research analyst reports. Scotiabank raised their price target on UiPath from $12.00 to $13.00 and gave the company a "sector perform" rating in a report on Friday, May 30th. Wall Street Zen lowered UiPath from a "strong-buy" rating to a "buy" rating in a report on Sunday, August 3rd. BMO Capital Markets lifted their target price on UiPath from $11.50 to $15.50 and gave the stock a "market perform" rating in a report on Friday, May 30th. Barclays reaffirmed an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Finally, Evercore ISI lifted their target price on UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a report on Friday, May 30th. Two investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $13.83.
Check Out Our Latest Stock Report on UiPath
UiPath Stock Performance
PATH traded down $0.14 during trading on Friday, reaching $11.12. The company had a trading volume of 7,783,026 shares, compared to its average volume of 10,100,680. The firm's 50-day simple moving average is $11.91 and its 200 day simple moving average is $11.95. The company has a market cap of $5.95 billion, a price-to-earnings ratio of -92.66, a PEG ratio of 14.57 and a beta of 1.03. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93.
UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. The firm had revenue of $356.62 million for the quarter, compared to analysts' expectations of $332.17 million. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%.UiPath's revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $0.13 EPS. On average, sell-side analysts expect that UiPath, Inc. will post -0.17 EPS for the current year.
UiPath Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Further Reading

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.